RTTNews | Oct 20, 2021 07:41AM EDT

07:41 Wednesday, October 20, 2021 (RTTNews.com) - While reporting financial results for the third quarter on Wednesday, Abbott Laboratories (ABT) raised its earnings and adjusted earnings guidance for the full-year 2021.

For fiscal 2021, the company continues to project earnings from continuing operations in a range of $3.55 to $3.6 per share and adjusted earnings from continuing operations in a range of $5.00 to $5.10 per share.

Previously, the company expected earnings from continuing operations in the range of $2.75 to $2.95 per share and adjusted earnings from continuing operations in a range of $4.30 to $4.50 per share, reflecting strong double-digit growth from last year.

On average, 25 analysts polled by Thomson Reuters expect the company to report earnings of $4.45 per share for the year. Analysts' estimates typically exclude special items.

On September 15, 2021, the board of directors of Abbott declared the company's quarterly cash dividend of $0.45 per share, payable November 15, 2021 to shareholders of record at the close of business on October 15, 2021.

Read the original article on RTTNews ( https://www.rttnews.com/3233989/abbott-laboratories-boosts-fy21-outlook-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved